v3.26.1
Condensed Statements of Stockholders Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Begining Balance (Shares) at Dec. 31, 2024   24,034,672    
Begining Balance at Dec. 31, 2024 $ 4,478 $ 2 $ 54,695 $ (50,219)
Issuance of common stock upon equity financing, net of issuance cost,shares   11,523,810    
Issuance of common stock upon equity financing, net of issuance cost, amount 10,803 $ 2 10,801 0
Stock-based compensation expense 288 0 288 0
Net loss (2,420) $ 0 0 (2,420)
Issuance of common stock upon exercise of pre-funded common warrants, shares   951,500    
Issuance of common stock upon exercise of pre-funded common warrants, amount 0 $ 0 0 0
Issuance of restricted stock awards, shares   30,000    
Issuance of restricted stock awards, amount 0 $ 0 0 0
Issuance of common stock upon exercise of stock options, shares   6,770    
Issuance of common stock upon exercise of stock options, amount 8 $ 0 8 0
Ending Balance (Shares) at Mar. 31, 2025 13,157 $ 4 65,792 (52,639)
Ending Balance at Mar. 31, 2025   36,546,752    
Begining Balance (Shares) at Dec. 31, 2024   24,034,672    
Begining Balance at Dec. 31, 2024 4,478 $ 2 54,695 (50,219)
Net loss (5,315)      
Ending Balance (Shares) at Jun. 30, 2025 10,641 $ 4 66,171 (55,534)
Ending Balance at Jun. 30, 2025   36,645,884    
Begining Balance (Shares) at Mar. 31, 2025   36,546,752    
Begining Balance at Mar. 31, 2025 13,157 $ 4 65,792 (52,639)
Stock-based compensation expense 345 0 345 0
Net loss (2,895) $ 0 0 (2,895)
Issuance of restricted stock awards, shares   41,000    
Issuance of restricted stock awards, amount 0 $ 0 0 0
Issuance of common stock upon exercise of stock options, shares   32,880    
Issuance of common stock upon exercise of stock options, amount 9 $ 0 9 0
Issuance of common stock upon exercise of common stock warrants, shares   25,252    
Issuance of common stock upon exercise of common stock warrants, amount 25 $ 0 25 0
Ending Balance (Shares) at Jun. 30, 2025 10,641 $ 4 66,171 (55,534)
Ending Balance at Jun. 30, 2025   36,645,884    
Begining Balance (Shares) at Dec. 31, 2025   36,613,916    
Begining Balance at Dec. 31, 2025 5,422 $ 4 66,805 (61,387)
Issuance of common stock upon equity financing, net of issuance cost,shares   8,438,790    
Issuance of common stock upon equity financing, net of issuance cost, amount 9,047 $ 1 9,046 0
Stock-based compensation expense 317 0 317 0
Net loss (3,521) 0 0 (3,521)
Ending Balance (Shares) at Mar. 31, 2026 11,265 $ 5 76,168 (64,908)
Ending Balance at Mar. 31, 2026   45,052,706    
Begining Balance (Shares) at Dec. 31, 2025   36,613,916    
Begining Balance at Dec. 31, 2025 5,422 $ 4 66,805 (61,387)
Net loss $ (6,432)      
Issuance of common stock upon exercise of stock options, shares 0      
Ending Balance (Shares) at Jun. 30, 2026 $ 8,979 $ 5 76,793 (67,819)
Ending Balance at Jun. 30, 2026   45,121,982    
Begining Balance (Shares) at Mar. 31, 2026   45,052,706    
Begining Balance at Mar. 31, 2026 11,265 $ 5 76,168 (64,908)
Stock-based compensation expense 570 0 570 0
Net loss (2,911) $ 0 0 (2,911)
Issuance of restricted stock awards, shares   69,276    
Issuance of restricted stock awards, amount 0 $ 0 0 0
Equity financing costs 55 0 55 0
Ending Balance (Shares) at Jun. 30, 2026 $ 8,979 $ 5 $ 76,793 $ (67,819)
Ending Balance at Jun. 30, 2026   45,121,982